HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

TU2670

GnRH antagonist; no structure available

Also Known As:

SKI2670

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- TU2670: 2

Experts

1.	Kim, Hun-Taek: 2 articles (01/2021 - 10/2015)
2.	Kim, Seon Mi: 2 articles (01/2021 - 10/2015)
3.	Bae, Kyun-Seop: 1 article (01/2021)
4.	Cho, Sang-Heon: 1 article (01/2021)
5.	Cho, Yong-Soon: 1 article (01/2021)
6.	Choe, Sangmin: 1 article (01/2021)
7.	Choi, SangKeun: 1 article (01/2021)
8.	Ghim, Jong-Lyul: 1 article (01/2021)
9.	Han, Sungpil: 1 article (01/2021)
10.	Jung, Jinah: 1 article (01/2021)

Related Diseases

1.	Endometriosis 10/15/2015 - "To investigate in vivo efficacy of SKI2670, regression of ectopic implants by repeated administration of SKI2670 was examined in a rat endometriosis model. " 10/15/2015 - "Our findings demonstrate robust GnRH antagonistic efficacy of SKI2670 in animal models, suggesting that SKI2670-induced suppression of the hypothalamic-pituitary-gonadal axis may be beneficial for the treatment of gonadal-hormone-dependent diseases such as endometriosis in humans."
2.	Hemorrhage 01/01/2021 - "A total of 16 healthy premenopausal women (23 to 45 years of age) were randomized and received 20, 40, 80, and 160 mg TU2670 (GnRH antagonist) or placebo 7 days (±1 day) after the onset of menstrual bleeding. "

Related Drugs and Biologics

1.	Gonadotropin-Releasing Hormone (GnRH)
2.	Gonadal Hormones